Paulson Funds Rise

Jul 1 2014 | 8:32am ET

Two Paulson & Co. strategies have outdone their peers through the first five months of the year, the firm told clients at its mid-year meeting.

The New York-based hedge fund’s credit opportunities fund is up 6.6% through the end of May, Reuters reports. Firm founder John Paulson said at the June 12 event in London that the portfolio is “fully invested” and designed to continue to earn such returns through next year, “outperforming in a low-yielding environment.”

Paulson also discussed the firm’s merger arbitrage strategy, which is up 3.3% over the same period. He said that merger arbitrage spreads are “becoming attractive,” citing Valeant Pharmaceuticals International’s hostile bid for Allergan Inc. and Mallinckrodt’s deal for Questor Pharma.

The talk came some two weeks before Paulson announced a big stake in Allergan and his support for Valeant’s offer, on which it is working with Pershing Square Capital Management.


In Depth

OmniQuest Capital: Why Funds of Hedge Funds Work

Aug 11 2016 | 4:47pm ET

There have been few sectors of the alternative investment universe under as much...

Lifestyle

Vortic: Making Great American Watches Again

Jul 25 2016 | 6:29pm ET

If you are compelled by stories of entrepreneurial vision & drive, or simply...

Guest Contributor

Old Hill Partners: Embrace Illiquidity

Aug 9 2016 | 2:39pm ET

The age-old financial concept that higher yields are the result of higher risk and...